Prostate Cancer Genetic Risk Evaluation and Screening Study — Stella

Clinical trial discovery in plain English. Data sourced from ClinicalTrials.gov.

About Browse conditions ClinicalTrials.gov ↗

Stella is not a medical provider and does not give medical advice. AI-generated summaries are for informational purposes only. Always consult your doctor before making any healthcare decisions.

Prostate Cancer Genetic Risk Evaluation and Screening Study — Stella

Home/Prostatic Neoplasm/

View on ClinicalTrials.gov

Recruiting

Back to Prostatic Neoplasm trials

Trial locations(1 site)

United States

Massachusetts General Hospital, Boston, Massachusetts

Key details

Sponsor

Massachusetts General Hospital

Enrollment target

~400 participants

Started

February 2020

Primary completion

December 2030

Age range

35 Years – 74 Years

Sex

Male only

Last updated October 2024

Interested in joining?

Tell us you're interested and we'll help connect you with the research team. We'll never share your email without your permission.

Your name

Email address

Stella acts as an intermediary. Researcher contact info is never exposed.

Follow this trial

Get notified in plain English when this trial's status changes. No account required.